2.44
price up icon4.72%   0.11
pre-market  Pre-mercato:  2.46   0.02   +0.82%
loading
Precedente Chiudi:
$2.33
Aprire:
$2.36
Volume 24 ore:
59,126
Relative Volume:
2.17
Capitalizzazione di mercato:
$2.71M
Reddito:
-
Utile/perdita netta:
$-6.07M
Rapporto P/E:
-0.4221
EPS:
-5.78
Flusso di cassa netto:
$-7.34M
1 W Prestazione:
-9.63%
1M Prestazione:
-57.84%
6M Prestazione:
-74.32%
1 anno Prestazione:
-87.24%
Intervallo 1D:
Value
$2.27
$2.54
Intervallo di 1 settimana:
Value
$2.27
$2.9128
Portata 52W:
Value
$2.27
$32.50

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
Nome
Adial Pharmaceuticals Inc
Name
Telefono
434-422-9800
Name
Indirizzo
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
Dipendente
7
Name
Cinguettio
@AdialPharma
Name
Prossima data di guadagno
2024-12-12
Name
Ultimi documenti SEC
Name
ADIL's Discussions on Twitter

Compare ADIL vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ADIL
Adial Pharmaceuticals Inc
2.44 2.59M 0 -6.07M -7.34M -5.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
487.43 122.19B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
772.19 83.21B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
840.28 51.13B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
332.85 43.68B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
369.00 41.01B 4.98B 69.60M 525.67M 0.5198

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-14 Iniziato Rodman & Renshaw Buy
2018-10-30 Iniziato Maxim Group Buy
2018-10-11 Iniziato Dawson James Buy

Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie

pulisher
Feb 24, 2026

ARMISTICE CAPITAL, LLC Acquires Shares in Adial Pharmaceuticals Inc - GuruFocus

Feb 24, 2026
pulisher
Feb 24, 2026

Key facts: Adial Pharmaceuticals meets Nasdaq bid requirement; advances AD04 to Phase 3 trial - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Adial Pharmaceuticals Regains Nasdaq Compliance, Advances AD04 Program - TipRanks

Feb 24, 2026
pulisher
Feb 24, 2026

Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement - Bitget

Feb 24, 2026
pulisher
Feb 24, 2026

Adial Pharmaceuticals regains full compliance with Nasdaq listing requirement - marketscreener.com

Feb 24, 2026
pulisher
Feb 24, 2026

Adial Regains Nasdaq Compliance as AD04 Advances, Engages in Partnering Talks - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Adial Pharmaceuticals eyes single pivotal trial path for AD04 - Investing.com India

Feb 24, 2026
pulisher
Feb 23, 2026

Adial Pharmaceuticals eyes single pivotal trial path for AD04 By Investing.com - Investing.com Australia

Feb 23, 2026
pulisher
Feb 23, 2026

Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One - Bitget

Feb 23, 2026
pulisher
Feb 23, 2026

Adial Pharmaceuticals stock rises on FDA policy shift - Investing.com

Feb 23, 2026
pulisher
Feb 23, 2026

Adial Pharmaceuticals stock rises on FDA policy shift By Investing.com - Investing.com UK

Feb 23, 2026
pulisher
Feb 23, 2026

Adial Pharmaceuticals (ADIL) Sees Potential in FDA's New Approva - GuruFocus

Feb 23, 2026
pulisher
Feb 23, 2026

New FDA trial policy could speed addiction drug for heavy drinkers - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Portfolio Shifts: Can Adial Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Volume & Consistent Profit Alerts - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 19, 2026

Alcohol Use Disorder Pipeline 2026: Latest FDA Approvals, Clinical Trials, And Emerging Therapies Assessment By Delveinsight Alkermes, Teva Pharma, Biocorrx, Inc., Adial Pharma, ADDEX THERAPEUTICS - Mena FN

Feb 19, 2026
pulisher
Feb 18, 2026

Fund Flows: Whats the beta of Adial Pharmaceuticals Inc stockCPI Data & Technical Entry and Exit Alerts - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 17, 2026

Adial Pharmaceuticals to Present at Oppenheimer Conference - Intellectia AI

Feb 17, 2026
pulisher
Feb 17, 2026

Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Bitget

Feb 17, 2026
pulisher
Feb 16, 2026

Litchfield Hills Research Estimates ADIL FY2025 Earnings - Defense World

Feb 16, 2026
pulisher
Feb 15, 2026

ADIL Technical Analysis & ETF Price Forecast - Intellectia AI

Feb 15, 2026
pulisher
Feb 14, 2026

Can Adial Pharmaceuticals Inc. outperform under higher oil pricesEarnings Growth Summary & Low Risk Entry Point Tips - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Buyback Watch: Whats the beta of Adial Pharmaceuticals Inc stockSell Signal & Community Consensus Picks - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 13, 2026

Will Adial Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Will Adial Pharmaceuticals Inc. benefit from geopolitical trends2025 Macro Impact & Growth Focused Entry Point Reports - mfd.ru

Feb 12, 2026
pulisher
Feb 09, 2026

Market Leaders: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 06, 2026

Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN

Feb 06, 2026
pulisher
Feb 05, 2026

Why Is Adial Pharmaceuticals Stock (ADIL) Down Today? - TipRanks

Feb 05, 2026
pulisher
Feb 04, 2026

Key facts: Adial Pharmaceuticals to execute reverse stock split; supports FDA trial - TradingView

Feb 04, 2026
pulisher
Feb 04, 2026

Dow Jumps Over 200 Points; Uber Shares Fall After Q4 Results - Benzinga

Feb 04, 2026
pulisher
Feb 04, 2026

Adial Pharmaceuticals Commends Congressional Directive for Alternative Clinical Trial Endpoints in Substance Use Disorder Treatments - Quiver Quantitative

Feb 04, 2026
pulisher
Feb 04, 2026

Adial Pharma To Effect 1 For 25 Reverse Stock Split To Regain Nasdaq Compliance; Shares Plunge - Nasdaq

Feb 04, 2026
pulisher
Feb 04, 2026

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 - marketscreener.com

Feb 04, 2026
pulisher
Feb 04, 2026

Super Micro Computer Q2 Earnings Exceed Expectations - Intellectia AI

Feb 04, 2026
pulisher
Feb 04, 2026

Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 04, 2026
pulisher
Feb 04, 2026

Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today? - Menafn.com

Feb 04, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment - Intellectia AI

Feb 03, 2026
pulisher
Feb 03, 2026

U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat - Intellectia AI

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split - Investing.com Nigeria

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split By Investing.com - Investing.com South Africa

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals (ADIL) Announces 1-for-25 Reverse Stock Sp - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com India

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals Announces Reverse Stock Split - citybiz

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement - The Manila Times

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Adial Pharmaceuticals Announces Reverse Stock Split to - GlobeNewswire

Feb 03, 2026
pulisher
Feb 02, 2026

Retail Trends: Is Adial Pharmaceuticals Inc affected by consumer sentimentStop Loss & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 02, 2026

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 24.9% in January - Defense World

Feb 02, 2026
pulisher
Jan 31, 2026

Trading Recap: Will Adial Pharmaceuticals Inc benefit from government policy2025 EndofYear Setup & High Conviction Buy Zone Picks - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Performance Recap: What is Bit Digital Incs market positionWeekly Trend Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 30, 2026

Aug Shorts: Does TELO have declining or rising EPSStock Surge & AI Enhanced Execution Alerts - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 29, 2026

Aug Mood: How sensitive is FS Bancorp Inc to inflationQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn

Jan 29, 2026

Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$101.05
price up icon 0.20%
$28.26
price up icon 1.80%
$104.83
price up icon 1.10%
$110.89
price up icon 0.87%
$158.62
price down icon 0.26%
biotechnology ONC
$369.00
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):